You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR DIENOGEST; ESTRADIOL VALERATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Dienogest; Estradiol Valerate

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00293059 ↗	Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding	Completed	Bayer	Phase 3	2005-12-01	The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00307801 ↗	Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding	Completed	Bayer	Phase 3	2006-02-01	The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
NCT00335218 ↗	Fat Distribution in Healthy Early Postmenopausal Women	Completed	Bayer	Phase 4	2002-07-01	The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.
NCT00764881 ↗	Effects of SH T00658ID on Libido	Completed	Bayer	Phase 3	2009-01-01	The aim of the study is to investigate whether women on oral contraceptives (OCs) suffering from acquired OC-associated female sexual dysfunction (FSD) for at least 3 months but no longer than one year will express the same level of sexual distress when taking SH T00658ID compared to Microgynon, the usual OC prescribed for women with OC-associated FSD.
NCT00778609 ↗	Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache	Completed	Bayer	Phase 3	2008-12-01	The aim of the present study is to investigate whether women taking a new combined oral contraceptive pill (SH T00658ID, estradiol valerate/dienogest) experience fewer hormone withdrawal-associated symptoms such as pelvic pain or headache during their monthly cycle compared to a commonly used contraceptive pill (Microgynon).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Dienogest; Estradiol Valerate

Condition Name

Chart
Table

Condition Name for Dienogest; Estradiol Valerate
Intervention	Trials
Contraception	4
Metrorrhagia	3
Oral Contraceptive	1
Ovarian Reserve	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Dienogest; Estradiol Valerate
Intervention	Trials
Metrorrhagia	3
Hemorrhage	3
Uterine Hemorrhage	2
Endometriosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Dienogest; Estradiol Valerate

Trials by Country

Map
Table

Trials by Country for Dienogest; Estradiol Valerate
Location	Trials
United States	20
China	20
Germany	18
Australia	11
United Kingdom	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Dienogest; Estradiol Valerate
Location	Trials
Nevada	1
Indiana	1
Illinois	1
Georgia	1
Florida	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Dienogest; Estradiol Valerate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Dienogest; Estradiol Valerate
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	6
Phase 2	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Dienogest; Estradiol Valerate
Clinical Trial Phase	Trials
Completed	13
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dienogest; Estradiol Valerate

Sponsor Name

Chart
Table

Sponsor Name for Dienogest; Estradiol Valerate
Sponsor	Trials
Bayer	10
Estetra	1
Adana Numune Training and Research Hospital	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Dienogest; Estradiol Valerate
Sponsor	Trials
Industry	12
Other	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.